Abstract = 200; Main text = 2996
Introduction
Epidemiologic studies commonly focus on investigating the effect of an exposure on a health outcome at the individual level, while accommodating variation at the upper level of a hierarchy within a multilevel framework. Interest may alternatively lie in the evaluation of differences across an upper level, for instance when seeking to evaluate the performance of healthcare provision, or to assess the effect of provider-level factors on patient outcomes. In this situation, a fair comparison can only follow if individuals' characteristics (such as demographics) and the severity of the health condition ('casemix') are balanced across providers. These circumstances are not very plausible for most aspects of healthcare provision due to inherent heterogeneity in the characteristics of individuals entering the healthcare system, dependent in part upon geography of residence.
1 This patient-level heterogeneity, or 'casemix', leads to differential access to care, a form of differential selection. Further, we expect that patient care
will vary by characteristics of the health condition (e.g. stage of diagnosis for cancer, previous case history of myocardial infarction) and features of their healthcare provider (e.g. available specialist, level of post-operative care), all of which likely impact patient-level health outcomes and contribute to any measured performance differences between providers.
Different modelling approaches are required at each level of a hierarchy when accounting for both patient casemix (which involves prediction methodology) and the evaluation of potential causal influences operating at the upper level (which involves causal inference methodology). Strategies that adjust for differential selection (e.g. matching, 2 stratification, 3 regression 3 and propensity score analysis 4, 5 ) are not readily adaptable to model separately the causal influences operating at the patient and provider levels; they may even introduce bias within such a complex analytical setting. [6] [7] [8] We propose multilevel latent class (MLC) modelling to exploit the inherent hierarchy of patients nested within healthcare providers, by partitioning the prediction focus at the individual level and the causal inference focus at the provider level. This paper extends the approach established in previous work 9 to include putative causal covariates at the provider level (modelled here as National Health Service Trusts)
to estimate the causal influence of provider characteristics on patient outcomes while accounting for the differential selection of patient casemix. We use simulated data to demonstrate proof of principle by exploring the extent to which the MLC model can recover simulated provider-level covariate causal effects.
Methods

Data simulation
We simulated data based on a previously utilized health dataset, 9, 10 to reflect real-world data. The simulated data comprised 24,640 patients and 19 National Health Service Trusts. Figure 1 illustrates the overarching simulation approach to the patient and Trust levels.
[Insert Figure 1 here]
We first simulated the patient-level covariates age (at diagnosis), sex, and socio-economic status (the Townsend score of material deprivation) using a trivariate covariance matrix informed by real data.
Values were drawn randomly from a normal distribution, and sex was categorized as male or female according to the median threshold. Age and socio-economic status were centered on their mean values; standard deviations were defined as per the real dataset: age standard deviation = 11.6, socio-economic status standard deviation = 3.18. Patient-level data were simulated to be homogeneous. Patients were then randomly assigned to Trusts, and Trust sizes were allowed to vary to reflect differing sizes of geographical area.
At the Trust level, we simulated both binary and continuous effects, although we analyzed them separately. These effects represent competing and causally independent features operating at the [Insert Table 2 here]
Multilevel Latent Class (MLC) analysis
In standard latent class analysis, 11, 12 observations are probabilistically assigned to classes with each observation having a probability of belonging to each latent class, and observations fully assigned across all classes. Multilevel latent class (MLC) models 13, 14 are an extension of single-level latent class analysis with observations probabilistically assigned to latent classes at all levels of the hierarchy. Assignment to classes at the lower level is based on similarities in characteristics, 15 leading to homogeneous latent classes at this level, while latent classes at the upper level may be based on either similarities or differences, dependent on model specification and the research question sought. An optimum solution for all classes at all levels is sought simultaneously using maximum likelihood estimation. With patient casemix accommodated through standard prediction strategies, and the MLC model constraint that patient-level classes are balanced across Trust-level classes, any residual differences in patient outcomes are due to unmodelled causal effects operating at the Trust level. We simulated these effects, so our interest is in the comparison between simulated and recovered Trust-level covariate coefficient values. As a minimum, 2 Trust classes are required to distinguish outcome differences; more than 2 classes allow for greater flexibility in modelling variations at the Trust level.
Trust-level coefficient recovery
We modelled each simulated dataset using the approach described and calculated a weighted mean outcome for each Trust based on probabilistic assignment to Trust class. Values of the Trust-level coefficient (! " ) were recovered using single-level regression analysis. We repeated this process for all simulated datasets, and calculated medians and credible intervals (CI: 2.5%, 97.5%) over each set of 100 repeated simulation datasets, for each MLC model scenario, simulated Trust-level coefficient parameter value, and error variance.
Software
Stata v14.2 19 was used to perform the simulations, collation of results and single-level linear regression analyses. Latent GOLD 20, 21 was used for all latent variable models, which incorporates an adapted expectation-maximization algorithm 13 for maximum likelihood estimation.
Results
Binary Trust-level covariate Table 3 shows the results of the analyses for the binary Trust-level covariate. Results were consistent across simulation seeds; models contained 1 patient class (1P) and up to 4 Trust classes (4T).
[Insert Table 3 here]
For all combinations, the simulated values of the Trust-level coefficient (! " ) were within credible intervals for each recovered ! " value, and results were consistent across different models and error variances. The median recovered ! " was almost identical to the simulated ! " for all simulated values except the lowest, regardless of error variance or MLC model. In general, as the error variance increases, the credible intervals became gradually wider, as would be expected, but differences were small.
For the lowest simulated ! " value of 0.027, the recovered ! " value reduces as the error variance increases (from 0.017-0.018 at the 33% error variance to 0.012-0.013 at the 67% error variance), and some ! " coefficients could not be recovered due to some simulated datasets yielding the same probability of class membership for each of the 19 Trusts. We hypothesize that, at very small values of ! " , the noise introduced when simulating data dominates the value of the ! " coefficient and the modelling process is unable to divide the Trusts into identifiably different Trust classes. The number of datasets excluded was small (0-1 at the 33% error variance, 0-5 at the 50% error variance, and 4-11 at the 67% error variance), but some bias may have occurred. Figure 2 shows the results from table 3 plotted by error variance, demonstrating that the line of equality (where recovered ! " equals simulated ! " ) lies almost exactly on the data points and is well within the credible intervals. We included all MLC models and made no distinction between the number of Trust classes.
[Insert Figure 2 here]
Continuous Trust-level covariate Table 4 shows the results of the analyses for the continuous Trust-level covariate. Results were consistent across simulation seeds; models contained one patient class (1P) and up to five Trust classes (5T), to reflect the gradual improvement seen as the number of Trust classes increase, revealing how model robustness may warrant more Trust classes than deemed most parsimonious (in contrast to typical latent class modelling strategies that may favor fewer classes to minimize model complexity).
[Insert Table 4 For the lowest simulated ! " value of 0.027, the median returned value does not differ much across MLC models, and the credible intervals increase only slightly as the error variance increases. There was a similar, though attenuated, pattern seen for the second lowest simulated ! " value of 0.053. Again, some datasets were excluded for the same reasons as described for the binary Trust-level covariate, both for the lowest ! " value of 0.027 (41-53 at the 33% error variance, 43-57 at the 50% error variance, and 46-61 at the 67% error variance), and the second lowest ! " value of 0.053 (0-4 at the 50% error variance, and 2-6 at the 67% error variance). We therefore excluded the lowest simulated value of ! " from any further investigation into the relationship between simulated and recovered values, as too few datasets are included to rely on the results observed. 
[Insert Figures 3-5 here]
Sensitivity analyses
In real-world situations, Trust sizes might vary, the division of the binary Trust-level covariate (currently ±0.5) might differ more than we have initially simulated, and the continuous Trust-level covariate (currently ranging from -0.5 to +0.5) may be duplicated across Trusts. To assess the sensitivity of our simulations, we amended each of these aspects individually; we found that none of these choices affected model outcomes. Lower simulated values of the Trust-level coefficients were not recovered as well as higher values, and datasets were excluded when these coefficients could not be recovered at all. It is possible that the variability introduced in the covariates during simulation dominates the coefficient parameter value such that it is harder to estimate within the modelling process. Bias may also exist due to dataset exclusions. It is reassuring, therefore, that these values remain within credible intervals of the recovered values.
Discussion
The illustrated MLC approach has several advantages. We have partitioned modelling for prediction (casemix adjustment) and for causal inference (assessing the putative causal impact of Trust characteristics) at different levels of the data structure, thus performing adjustment for differential selection at the patient level while allowing for investigation of causal insights at the Trust level. This serves to overcome the potential conflict between two distinctly separate analytical strategies.
Uncertainty surrounding class membership is implicit within the latent classes, since observations may belong to all classes, with probabilities determined empirically; the latent class approach therefore accommodates uncertainty better than standard regression modelling. Unlike other casemix adjustment strategies, this approach accommodates both patient-level variation due to unmeasured covariates, and measurement uncertainty within observed covariates, all within the latent constructs adopted.
There is much scope for extension and further development. For simplification, and proof of principle,
we analyzed competing and causally independent binary and continuous Trust-level covariate effects separately, making the assessment of total causal effect straightforward. Multiple covariates can logically be included in combination at the Trust level within a robust causal framework, 22 supported by the construction of a multivariable directed acyclic graph (DAG) 23 to resolve which covariates are required to address separate research questions pertaining to the putative causal impacts of each covariate in the DAG. 24 The same modelling framework may accommodate a binary outcome variable, although the fixed binomial error variance of > -3 ⁄ at the patient level has implications on the effect of the variance structure at higher levels, which may serve to distort the relationship between simulated and recovered values. Also for simplification, we simulated patient-level data to be homogeneous, and modelled using only 1 patient class. The MLC approach allows for any number of patient classes to be specified, to ensure casemix balance across Trust classes by accommodating patient heterogeneity. More complex simulations with mixtures of patient subgroups can therefore be explored in future evaluation.
Additional complexities in casemix (e.g. treatment variables) can also be incorporated, in combination with all other potential complexities -this is not typically considered within standard casemix modelling strategies, yet arguably it should be if we assume that the treatment given should part explain the heterogeneity in patient outcomes that are observed. 
